» Articles » PMID: 33407761

The Protective Effects of Phosphodiesterase-5 Inhibitor, Sildenafil on Post-resuscitation Cardiac Dysfunction of Cardiac Arrest: by Regulating the MiR-155-5p and MiR-145-5p

Overview
Publisher Biomed Central
Specialty Emergency Medicine
Date 2021 Jan 7
PMID 33407761
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MiRNA-155 and miRNA-145 have been demonstrated to function as a key regulator in the development of the cardiovascular system. Recent experimental and clinical studies have indicated the cardioprotective role of sildenafil during ischemia/reperfusion (I/R) injury. This study was designed to investigate if administration of sildenafil will attenuate post-resuscitation myocardial dysfunction by regulating miRNA-155 and miR-145 expressions.

Methods: Thirty-two male pigs (weighing 30 ± 2 kg) were randomly divided into 4 groups, sildenafil group (n = 8), sildenafil +NG-nitro-l-arginine methyl ester (L-NAME) (20 mg/kg L) group (n = 8), saline (SA group, n = 8); and sham operation group (sham group, n = 8). Eight minutes of untreated VF was followed by defibrillation in anesthetized, closed-chest pigs. Hemodynamic status and blood samples were obtained at 0 min, 0.5, 1, 2, 4 and 6 h after return of spontaneous circulation (ROSC), and the hearts were removed and analyzed under electron microscopy, quantitative real-time polymerase chain reaction and ultra structural analysis were performed to evaluate myocardial injury.

Results: Compared with the sildenafil + L-NAME and saline groups, the sildenafil group had better outcomes in terms of hemodynamic and oxygen metabolism parameters as well as 24-h survival rate, and attenuated myocardial injury; In this study, CA pigs showed evidently increased levels of miR-155-5p and miR-145-5p, while the sildenafil treatment decreased the levels of miR-155-5p and miR-145-5p in CA pigs. In addition, the levels of eNOS was decreased in CA pigs, validating sildenafil attenuating post-resuscitation myocardial dysfunction by regulating miRNA-155 and miR-145 expressions.

Conclusions: Sildenafil group had better outcomes in terms of hemodynamic and oxygen metabolism parameters as well as 24-h survival rate, inhibited the increases in the miR-155-5p and miR-145-5p levels and attenuated myocardial injury in a porcine model of CA and resuscitation.

Citing Articles

Inhibition of mir-155-5p alleviates cardiomyocyte pyroptosis induced by hypoxia/reoxygenation via targeting SIRT1-mediated activation of the NLRP3 inflammasome.

Lu Q, Shen Q, Su J, Li X, Xia B, Tang A J Cardiothorac Surg. 2025; 20(1):135.

PMID: 39972472 PMC: 11837669. DOI: 10.1186/s13019-025-03366-1.


Exploring the Multifaceted Potential of Sildenafil in Medicine.

Puscasu C, Zanfirescu A, Negres S, Seremet O Medicina (Kaunas). 2023; 59(12).

PMID: 38138293 PMC: 10744870. DOI: 10.3390/medicina59122190.


lncRNA ADAMTS9-AS1/circFN1 Competitively Binds to miR-206 to Elevate the Expression of ACTB, Thus Inducing Hypertrophic Cardiomyopathy.

Feng W, Han S Oxid Med Cell Longev. 2022; 2022:1450610.

PMID: 35401927 PMC: 8989615. DOI: 10.1155/2022/1450610.

References
1.
Wang Y, Jin L . miRNA-145 is associated with spontaneous hypertension by targeting SLC7A1. Exp Ther Med. 2018; 15(1):548-552. PMC: 5806230. DOI: 10.3892/etm.2017.5371. View

2.
Wu C, Li C, Zhang Y, Yang J, Yin Q, Hang C . Differences of postresuscitation myocardial dysfunction in ventricular fibrillation versus asphyxiation. Am J Emerg Med. 2013; 31(12):1690-6. DOI: 10.1016/j.ajem.2013.08.017. View

3.
Santovito D, Mandolini C, Marcantonio P, De Nardis V, Bucci M, Paganelli C . Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets. 2013; 17(3):217-23. DOI: 10.1517/14728222.2013.745512. View

4.
Zhang Q, Yuan W, Wang G, Wu J, Wang M, Li C . The protective effects of a phosphodiesterase 5 inhibitor, sildenafil, on postresuscitation cardiac dysfunction of cardiac arrest: metabolic evidence from microdialysis. Crit Care. 2014; 18(6):641. PMC: 4262990. DOI: 10.1186/s13054-014-0641-7. View

5.
Eisenhardt S, Weiss J, Smolka C, Maxeiner J, Pankratz F, Bemtgen X . MicroRNA-155 aggravates ischemia-reperfusion injury by modulation of inflammatory cell recruitment and the respiratory oxidative burst. Basic Res Cardiol. 2015; 110(3):32. DOI: 10.1007/s00395-015-0490-9. View